+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Nivalis Therapeutics Inc (NVLS) - Financial and Strategic SWOT Analysis Review

  • ID: 4278992
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Nivalis Therapeutics Inc (Nivalis Therapeutics), formerly N30 Pharmaceuticals is a pharmaceutical company that develops a novel class of disease modifying therapies, which can preserve intracellular GSNO in the pathophysiology of cystic fibrosis. The company carries out the discovery, development and commercialization of s-nitrosothiol drugs. It provides products for the treatment of respiratory and cardiopulmonary diseases such as cystic fibrosis, asthma and chronic obstructive pulmonary disease. Nivalis Therapeutics’ N91115 targets patients with the F508del mutation, which is the common disease causing mutation in cystic fibrosis. The company has developed small molecule inhibitors of the S-nitrosoglutathione reductase protein that can increase CFTR activity and decrease airway inflammation. Nivalis Therapeutics is headquartered in Boulder, Colorado, the US.

Nivalis Therapeutics Inc Key Recent Developments

May 01, 2017: Nivalis Therapeutics Reports First Quarter 2017 Financial Results
Feb 13, 2017: Nivalis Therapeutics Reports Fourth Quarter and Full-Year 2016 Financial Results
Jan 16, 2017: Nivalis Therapeutics unveils corporate restructuring
Jan 12, 2017: Nivalis Therapeutics Announces Corporate Restructuring

This comprehensive SWOT profile of Nivalis Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Nivalis Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Nivalis Therapeutics Inc - Key Information
  • Nivalis Therapeutics Inc - Overview
  • Nivalis Therapeutics Inc - Key Employees
  • Nivalis Therapeutics Inc - Key Employee Biographies
  • Nivalis Therapeutics Inc - Key Operational Heads
  • Nivalis Therapeutics Inc - Major Products and Services
  • Nivalis Therapeutics Inc - History
  • Nivalis Therapeutics Inc - Company Statement
  • Nivalis Therapeutics Inc - Locations And Subsidiaries
  • Nivalis Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Nivalis Therapeutics Inc - Business Description
  • Nivalis Therapeutics Inc - Corporate Strategy
  • Nivalis Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Nivalis Therapeutics Inc - Strengths
  • Nivalis Therapeutics Inc - Weaknesses
  • Nivalis Therapeutics Inc - Opportunities
  • Nivalis Therapeutics Inc - Threats
  • Nivalis Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Nivalis Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Nivalis Therapeutics Inc, Key Information
  • Nivalis Therapeutics Inc, Key Ratios
  • Nivalis Therapeutics Inc, Share Data
  • Nivalis Therapeutics Inc, Major Products and Services
  • Nivalis Therapeutics Inc, History
  • Nivalis Therapeutics Inc, Key Employees
  • Nivalis Therapeutics Inc, Key Employee Biographies
  • Nivalis Therapeutics Inc, Key Operational Heads
  • Nivalis Therapeutics Inc, Other Locations
  • Nivalis Therapeutics Inc, Subsidiaries
  • Nivalis Therapeutics Inc, Key Manufacturing facilities
  • Nivalis Therapeutics Inc, Key Competitors
  • Nivalis Therapeutics Inc, SWOT Analysis
  • Nivalis Therapeutics Inc, Ratios based on current share price
  • Nivalis Therapeutics Inc, Annual Ratios
  • Nivalis Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Nivalis Therapeutics Inc, Performance Chart
  • Nivalis Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown